Clinical Trial Update: Optimal Dose of Omeprazole After Endoscopic Treatment of Bleeding Peptic Ulcers [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating the optimal dose of omeprazole after endoscopic treatment of bleeding peptic ulcers has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Peptic Ulcer Disease

Drugs mentioned

• PRILOSEC (Omeprazole magnesium)

Snippet

Sponsor: Singapore General Hospital | Conditions: Bleeding Peptic Ulcers Disease | Phase 3 | Status: COMPLETED